Insilico Medicine is an AI-driven biotechnology company that leverages generative AI, deep learning, and reinforcement learning to accelerate drug discovery and development. The company focuses on end-to-end drug discovery, including target identification, generation of novel molecular structures, and prediction of clinical trial outcomes. Insilico Medicine's platform, Pharma.AI, integrates multiple AI models to streamline the drug development pipeline, reduce costs, and improve success rates in bringing new therapeutics to market. The company also explores applications in aging research and personalized medicine.
We don't have vendor details for Insilico Medicine yet. Know the provider's website?
Discover EU-based alternatives for this AI application.
